Related Experiment Video
Updated: May 12, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Updates to gene-disease classifications and inheritance patterns for porphyrias.
Emily Brown Reeves1, William Hankey2, Pepper St Clair2
1Nutriplexity, Bremerton, WA, United States.
This study streamlines genetic diagnostics for porphyrias by consolidating gene-disease relationships within the heme synthesis pathway. This approach improves variant interpretation and reporting accuracy for rare genetic disorders.
Area of Science:
- Biochemistry
- Genetics
- Medical Diagnostics
Background:
- Porphyrias are a group of genetic disorders caused by pathogenic variants in heme synthesis pathway genes.
- Delayed diagnosis of porphyrias is common due to nonspecific and episodic symptoms.
- Accurate genetic diagnostics are crucial for timely porphyria management.
Purpose of the Study:
- To perform comprehensive gene-disease curations for all genes in the heme synthesis pathway.
- To address challenges in porphyria diagnosis stemming from variable inheritance patterns and overlapping variants.
- To establish improved nomenclature for gene-disease relationships in porphyrias.
Main Methods:
- Expert panel review and gene-disease curation for the eight enzyme-catalyzed steps of the heme synthesis pathway.
- Consolidation of distinct disease assertions (e.g., dominant vs. recessive) into single gene-disease entries.
- Development of novel, gene-based parent terms encompassing monoallelic and biallelic subtypes.
Main Results:
- Several heme synthesis genes (HMBS, UROD, CPOX, PPOX) exhibited multiple disease assertions, often differing by inheritance pattern.
- A unified approach ('lumping') was adopted for gene-disease curations, integrating patients from different disease subtypes.
- A semidominant inheritance pattern was assigned to parent terms to reflect overlapping variants and allele dosage effects on phenotypic severity.
Conclusions:
- The developed gene-disease curations for the heme synthesis pathway enhance downstream variant curation accuracy.
- This work provides a foundation for improved molecular diagnostic reporting of porphyrias.
- Clarified nomenclature facilitates precise variant interpretation and reporting in heme synthesis disorders.
Related Concept Videos
Pleiotropy
Pharmacogenomics: Identification of New Drug Targets
Pedigree Analysis
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

